A Case for Reviews

Christian Daughton's essay1 rightly criticizes scientists for being insufficiently familiar with research literature. I would extend Daughton's views by emphasizing the value of good review publications. Unfortunately, scientists have little incentive to write reviews, because reviews are typically undervalued by science administrators. Administrators value discovery and apparently do not appreciate the fact that writing a review can take as much or more time, effort, and creativity as doing the

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Many bench scientists cannot write good reviews, because they do not have the necessary skills in writing, critical thinking, insight, or creativity. The best review papers are often written by senior, experienced people. Such experience brings a breadth and depth of understanding that cannot be acquired in graduate school. Too many young scientists think that the only important science is that which is being done now or no more than a year or so ago.

There seems to be a special role here for older scientists who often do less bench research, because they have been "left behind" by new techniques, new research fads, new-era grant-review panels, or by a bias of grant agencies for young investigators. Older scientists can get "out in front" again by writing reviews, the need for which grows with the growth in primary literature.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • W.r. (bill) Klemm

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio